1 recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Recruiting 1 |
Follow MIBC: new trials by email Literature Review of MIBC trials Research Report on MIBC
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Neoadjuvant RC48 Plus Gemcitabine in HER2-Expressing MIBC Gemcitabine, Toripalimab, Disitamab Vedotin (RC48) - MIBC | Phase 3 | Recruiting | Zhiquan Hu | 170 | 2026-07-01 | 2026-07-09 |
Cystectomy (1) · Gemcitabine (1) · RC48 antibody (1) · disitamab vedotin (1) · toripalimab (1)
Zhiquan Hu (1)
China (1)